Cargando…

Neuromuscular Blocking Agents and Monitoring in China: A Cross-Sectional Survey of Current Management

BACKGROUND: Little is known about the recent use of neuromuscular blocking agents (NMBAs) and monitoring in China. This paper presents the results of a nationwide survey conducted to obtain information regarding the current management of NMBAs in China. METHODS: A questionnaire was sent to Chinese a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, HaoTian, Lin, ZengMao, Zhou, RuiHao, Huang, SuiSui, Chen, LingJun, Su, Yang, Cheng, LuoNa, Zhang, Huan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092066/ https://www.ncbi.nlm.nih.gov/pubmed/35572965 http://dx.doi.org/10.3389/fmed.2022.770105

Ejemplares similares

Current use of neuromuscular blocking agents and antagonists in Korea: a 2018 survey
por: Kim, Jin Sun, et al.
Publicado: (2019)

Prolonged neuromuscular blockade by non-depolarizing neuromuscular blocking agents
por: Higashi, Michiko, et al.
Publicado: (2019)

Residual neuromuscular block in the postanesthesia care unit: incidence, risk factors, and effect of neuromuscular monitoring and reversal agents
por: ÖZBEY, Nazlı Bahar, et al.
Publicado: (2022)

Flexible organic frameworks sequester neuromuscular blocking agents in vitro and reverse neuromuscular block in vivo
por: Wu, Yan, et al.
Publicado: (2022)

Neuromuscular blocking agents in the intensive care unit
por: Rodríguez-Blanco, Jonathan, et al.
Publicado: (2022)

Preferences of Mexican anesthesiologists for vecuronium, rocuronium, or other neuromuscular blocking agents: a survey
por: Nava-Ocampo, A A, et al.
Publicado: (2002)

Neuromuscular monitoring and neuromuscular blocking agent shortages when treating critically ill COVID-19 patients: a multicentre retrospective analysis
por: Ziatkowski-Michaud, Julia, et al.
Publicado: (2021)

Tracheal Intubation Without the Use of Neuromuscular Blocking Agents
por: Prakash, Smita
Publicado: (2012)

Neuromuscular blocking agents for acute respiratory distress syndrome
por: Torbic, Heather, et al.
Publicado: (2019)

A survey of the current use of neuromuscular blocking drugs among the Middle Eastern anesthesiologists
por: Eldawlatly, Abdelazeem, et al.
Publicado: (2013)

Reversal agent is mandatory even with neuromuscular monitoring!
por: Mehandale, Sripada Gopalakrishna, et al.
Publicado: (2018)

Urgent intubation without neuromuscular blocking agents and the risk of tracheostomy
por: Fujinaga, Jun, et al.
Publicado: (2019)

The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents
por: Honore, Patrick M., et al.
Publicado: (2020)

Sugammadex as a reversal agent for neuromuscular block: an evidence-based review
por: Schaller, Stefan Josef, et al.
Publicado: (2013)

Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents
por: Kim, Yong Byum, et al.
Publicado: (2017)

Potential cross-allergic reaction from pholcodine and neuromuscular blocking agents
Publicado: (2022)

Choice of neuromuscular block reversal agent to reduce postoperative pulmonary complications
por: Cho, Sung-Ae, et al.
Publicado: (2022)

Is it appropriate for acute respiratory distress syndrome patients with neuromuscular blocking agents?
por: Tan, Zhimin, et al.
Publicado: (2023)

Reversal of neuromuscular block
por: Bhalotra, Anju Romina
Publicado: (2018)

Neuromuscular blocking agents for acute respiratory distress syndrome: an updated meta-analysis of randomized controlled trials
por: Zheng, Zhongjun, et al.
Publicado: (2020)

Current Genetic Survey and Potential Gene-Targeting Therapeutics for Neuromuscular Diseases
por: Chiu, Wei, et al.
Publicado: (2020)

Threshold for basophil activation test positivity in neuromuscular blocking agents hypersensitivity reactions
por: Hagau, Natalia, et al.
Publicado: (2013)

Endotracheal Intubation Without Neuromuscular Blocking Agents: Is It a Good and Safe Option?
por: Akan, Mert, et al.
Publicado: (2012)

Erratum: Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents
por: Kim, Yong Beom, et al.
Publicado: (2017)

Novel Insights on MRGPRX2-Mediated Hypersensitivity to Neuromuscular Blocking Agents And Fluoroquinolones
por: Elst, Jessy, et al.
Publicado: (2021)

Neuromuscular blocking agents/nitric oxide: Lack of efficacy: 3 case reports
Publicado: (2021)

The effects of sevoflurane with propofol and remifentanil on tracheal intubation conditions without neuromuscular blocking agents
por: Kim, Wook Jong, et al.
Publicado: (2010)

Supramolecular therapeutics to treat the side effects induced by a depolarizing neuromuscular blocking agent
por: Zhang, Xiangjun, et al.
Publicado: (2019)

Use of Sedatives and Neuromuscular-Blocking Agents in Mechanically Ventilated Patients with COVID-19 ARDS
por: Ego, Amédée, et al.
Publicado: (2021)

Potentially disastrous reversal of neuromuscular block agents before removing Mayfield head holder
por: Santos, Christiano dos Santos e, et al.
Publicado: (2020)

Neuromuscular blocking agents in patients with acute respiratory distress syndrome: a summary of the current evidence from three randomized controlled trials
por: Pereira, VGM
Publicado: (2013)

Neuromuscular blocking agents in patients with acute respiratory distress syndrome: a summary of the current evidence from three randomized controlled trials
por: Neto, Ary Serpa, et al.
Publicado: (2012)

Neuromuscular block monitoring by smartphone application (i-TOF(©) system): an observational pilot study
por: Schiavoni, Lorenzo, et al.
Publicado: (2020)

Reversal agents: do we need to administer with neuromuscular monitoring – an observational study
por: Goyal, Shilpa, et al.
Publicado: (2018)

Response to comments on “Reversal agents: Do we need to administer with neuromuscular monitoring”
por: Goyal, Shilpa, et al.
Publicado: (2018)

Current Trends in Neuromuscular Blockade, Management, and Monitoring amongst Singaporean Anaesthetists
por: Teoh, Wendy H., et al.
Publicado: (2016)

Multiple cross-reactivity to several types of neuromuscular blocking agents in a patient with rocuronium anaphylaxis
por: Oh, Young-Jae, et al.
Publicado: (2013)

Provider variability in the intraoperative use of neuromuscular blocking agents: a retrospective multicentre cohort study
por: Althoff, Friederike C, et al.
Publicado: (2021)

Factors Associated with the Underuse of Sedatives and Neuromuscular Blocking Agents for Pediatric Emergency Endotracheal Intubation in Korea
por: Lee, Jeong-Yong, et al.
Publicado: (2022)

Allosteric inhibition of muscle-type nicotinic acetylcholine receptors by a neuromuscular blocking agent pancuronium
por: Sakata, Souhei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sgjmkj3ie7kq3hsi75ohbp1paq